InspireMD Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:NSPR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 May 26	BuyUS$17,500	Paul Stuka	Individual	20,000	US$0.88
19 May 26	SellUS$189,594	Shane Gleason	Individual	85,295	US$3.65
14 May 26	BuyUS$17,325	Paul Stuka	Individual	15,000	US$1.16
12 May 26	BuyUS$25,200	Marvin Slosman	Individual	21,000	US$1.20
11 May 26	BuyUS$88,026	Paul Stuka	Individual	75,626	US$1.19
07 May 26	BuyUS$106,200	Gary Roubin	Individual	90,000	US$1.18
07 May 26	BuyUS$9,034	Paul Stuka	Individual	7,895	US$1.15
07 May 26	BuyUS$102,638	Scott Ward	Individual	89,250	US$1.15
02 Feb 26	SellUS$86,487	Shane Gleason	Individual	53,285	US$1.66
29 Jan 26	SellUS$12,843	Shane Gleason	Individual	7,909	US$1.65
09 Dec 25	BuyUS$4,905	Paul Stuka	Individual	2,710	US$1.81
05 Dec 25	BuyUS$9,436	Paul Stuka	Individual	5,073	US$1.86
04 Dec 25	BuyUS$18,741	Paul Stuka	Individual	10,130	US$1.85
12 Nov 25	BuyUS$21,758	Paul Stuka	Individual	13,431	US$1.62
30 Jul 25	BuyUS$74,998	Thomas Kester	Individual	30,991	US$2.42
30 Jul 25	BuyUS$99,999	Gary Roubin	Individual	41,322	US$2.42
30 Jul 25	BuyUS$50,000	Osiris Capital Management	Company	20,661	US$2.42
30 Jul 25	BuyUS$24,999	Marvin Slosman	Individual	10,330	US$2.42

Insider Trading Volume

Insider Buying: NSPR insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NSPR?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	3,133,405	6.69%
Individual Insiders	7,713,420	16.5%
Hedge Funds	9,698,745	20.7%
Institutions	10,417,910	22.2%
General Public	15,875,482	33.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 52.9%.

Top Shareholders

Top 25 shareholders own 64.29% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.34%	Rosalind Advisors, Inc.	3,905,743	US$3.0m	0%	1.35%
7.21%	Nantahala Capital Management, LLC	3,376,484	US$2.6m	0%	0.17%
6.78%	Aberdeen Group Plc	3,173,364	US$2.4m	0%	no data
6.69%	OrbiMed Advisors LLC	3,133,405	US$2.4m	0%	0.04%
5.16%	Parkman Healthcare Partners LLC	2,416,518	US$1.8m	0%	0.2%
4.48%	Velan Capital Partners LP	2,099,652	US$1.6m	-2.05%	1.25%
3.97%	Marshall Wace LLP	1,860,405	US$1.4m	0%	no data
2.28%	Craig Shore	1,066,799	US$816.5k	0%	no data
2.25%	Shane Gleason	1,053,882	US$806.6k	-7.49%	no data
2.23%	Soleus Capital Management, L.P.	1,045,708	US$800.4k	-9.07%	0.03%
2.04%	Andrea Tommasoli	954,389	US$730.5k	31.2%	no data
1.78%	Gary Roubin	834,478	US$638.7k	12.1%	no data
1.48%	Michael Lawless	691,695	US$529.4k	-80.9%	no data
1.43%	Paul Stuka	667,871	US$511.2k	27.5%	no data
1.28%	Michael Berman	597,580	US$457.4k	17.3%	no data
0.98%	Thomas Kester	458,573	US$351.0k	0%	no data
0.96%	Pura Vida Investments, LLC	450,517	US$344.8k	0%	1.92%
0.9%	Osiris Capital Management	423,704	US$324.3k	-4.61%	68.29%
0.81%	Ingalls & Snyder, LLC	379,300	US$290.3k	-1.3%	0.01%
0.66%	Patrick Verta	308,532	US$236.2k	0%	no data
0.66%	Peter Ligotti	307,252	US$235.2k	0%	no data
0.65%	Kathryn Arnold	303,087	US$232.0k	0%	no data
0.53%	Affiance Financial, LLC	250,370	US$191.6k	0%	0.03%
0.51%	Scott Ward	237,096	US$181.5k	60.4%	no data
0.24%	Essex Investment Management Company, LLC	114,085	US$87.3k	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/10 12:03
End of Day Share Price	2026/06/10 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

InspireMD, Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Raymond Myers	Benchmark Company
Keay Nakae	Chardan Capital Markets, LLC
Jose De Jesus Haresco	Citizens JMP Securities, LLC